Oncologic Management of Hereditary Colorectal Cancer

Por Yacoub, George, Nagalla, Srikanth, Aklilu, Mebea
Publicado em 2012

Adjuvant Chemotherapy is Associated with Improved Survival in Patients with Stage II Colon Cancer

Por Casadaban, Leigh, Rauscher, Garth, Aklilu, Mebea, Villenes, Dana, Freels, Sally, Maker, Ajay V.
Publicado no Cancer (2016)

Reverse translation of phase I biomarker findings links the activity of angiotensin-(1–7) to repression of hypoxia inducible factor-1α in vascular sarcomas

Por Petty, W Jeffrey, Aklilu, Mebea, Varela, Victor A, Lovato, James, Savage, Paul D, Miller, Antonius A
Publicado em 2012

Phase II Trial of Adjuvant Oral Thalidomide Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Disease from Colorectal/Appendiceal...

Por Shen, Perry, Thomas, Christopher R., Fenstermaker, Joyce, Aklilu, Mebea, McCoy, Thomas P., Levine, Edward A.
Publicado em 2014

A brief yoga intervention implemented during chemotherapy: A randomized controlled pilot study

Por Sohl, Stephanie J., Danhauer, Suzanne C., Birdee, Gurjeet S., Nicklas, Barbara J., Yacoub, George, Aklilu, Mebea, Avis, Nancy E.
Publicado no Complement Ther Med (2016)

Optimal Timing of Systemic Therapy in Resectable Colorectal Liver Metastases

Por IHEMELANDU, CHUKWUEMEKA, LEVINE, EDWARD A., AKLILU, MEBEA, YACOUB, GEORGE, HOWERTON, RUSSELL, BOLEMON, BRITT, GRAHAM, MATTHEW, RUSSELL, GREG, SHEN, PERRY
Publicado em 2013

Outcomes of Patients With Esophageal Cancer Staged With [(18)F]Fluorodeoxyglucose Positron Emission Tomography (FDG-PET): Can Postchemoradiotherapy FDG-PET Predict the Utility of R...

Por Monjazeb, Arta Monir, Riedlinger, Greg, Aklilu, Mebea, Geisinger, Kim R., Mishra, Girish, Isom, Scott, Clark, Paige, Levine, Edward A., Blackstock, A. William
Publicado em 2010

A two-cohort phase 1 study of weekly oxaliplatin and gemcitabine, then oxaliplatin, gemcitabine and erlotinib during radiotherapy for unresectable pancreatic carcinoma

Por Raftery, Laura, Tepper, Joel E, Goldberg, Richard M., Blackstock, A. William, Aklilu, Mebea, Bernard, Stephen A., Ivanova, Anastasia, Davies, Janine M., O’Neil, Bert H.
Publicado em 2013

A randomized pilot phase I study of modified carcinoembryonic antigen (CEA) peptide (CAP1-6D)/montanide/GM-CSF-vaccine in patients with pancreatic adenocarcinoma

Por Geynisman, Daniel M, Zha, Yuanyuan, Kunnavakkam, Rangesh, Aklilu, Mebea, Catenacci, Daniel VT, Polite, Blase N, Rosenbaum, Cara, Namakydoust, Azadeh, Karrison, Theodore, Gajewski, Thomas F, Kindler, Hedy L
Publicado em 2013

A Phase II study of Capecitabine, Oxaliplatin, Bevacizumab and Cetuximab in the Treatment of Metastatic Colorectal Cancer

Por WONG, NAN SOON, FERNANDO, NISHAN H., NIXON, ANDREW B., CUSHMAN, STEPHANIE, AKLILU, MEBEA, BENDELL, JOHANNA C., MORSE, MICHAEL A., BLOBE, GERARD C., ASHTON, JILL, PANG, HERBERT, HURWITZ, HERBERT I.
Publicado em 2011

The effect of targeted agents on outcomes in patients with brain metastases from renal cell carcinoma treated with Gamma Knife surgery

Por Cochran, D. Clay, Chan, Michael D., Aklilu, Mebea, Lovato, James F., Alphonse, Natalie K., Bourland, J. Daniel, Urbanic, James J., McMullen, Kevin P., Shaw, Edward G., Tatter, Stephen B., Ellis, Thomas L.
Publicado em 2012

A Randomized Phase II Study of Immunization With Dendritic Cells Modified With Poxvectors Encoding CEA and MUC1 Compared With the Same Poxvectors Plus GM-CSF for Resected Metastati...

Por Morse, Michael A., Niedzwiecki, Donna, Marshall, John L., Garrett, Christopher, Chang, David Z., Aklilu, Mebea, Crocenzi, Todd S., Cole, David J., Dessureault, Sophie, Hobeika, Amy C., Osada, Takuya, Onaitis, Mark, Clary, Bryan M., Hsu, David, Devi, Gayathri R., Bulusu, Anuradha, Annechiarico, Robert P., Chadaram, Vijaya, Clay, Timothy M., Lyerly, H. Kim
Publicado em 2013